rs2069506
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005981.5(TSPAN31):c.*1781C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 1,346,344 control chromosomes in the GnomAD database, including 81,582 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6737 hom., cov: 32)
Exomes 𝑓: 0.34 ( 74845 hom. )
Consequence
TSPAN31
NM_005981.5 3_prime_UTR
NM_005981.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.205
Publications
20 publications found
Genes affected
TSPAN31 (HGNC:10539): (tetraspanin 31) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is thought to be involved in growth-related cellular processes. This gene is associated with tumorigenesis and osteosarcoma. [provided by RefSeq, Jul 2008]
CDK4 (HGNC:1773): (cyclin dependent kinase 4) The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq, Jul 2008]
CDK4 Gene-Disease associations (from GenCC):
- melanoma, cutaneous malignant, susceptibility to, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 12-57749071-C-A is Benign according to our data. Variant chr12-57749071-C-A is described in ClinVar as Benign. ClinVar VariationId is 1182049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.637 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TSPAN31 | NM_005981.5 | c.*1781C>A | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000257910.8 | NP_005972.1 | ||
| CDK4 | NM_000075.4 | c.819+111G>T | intron_variant | Intron 7 of 7 | ENST00000257904.11 | NP_000066.1 | ||
| TSPAN31 | NM_001330169.2 | c.*1781C>A | 3_prime_UTR_variant | Exon 6 of 6 | NP_001317098.1 | |||
| TSPAN31 | NM_001330168.2 | c.*1781C>A | 3_prime_UTR_variant | Exon 4 of 4 | NP_001317097.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.265 AC: 40291AN: 152066Hom.: 6734 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40291
AN:
152066
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.339 AC: 405229AN: 1194160Hom.: 74845 Cov.: 17 AF XY: 0.345 AC XY: 208953AN XY: 606228 show subpopulations
GnomAD4 exome
AF:
AC:
405229
AN:
1194160
Hom.:
Cov.:
17
AF XY:
AC XY:
208953
AN XY:
606228
show subpopulations
African (AFR)
AF:
AC:
2066
AN:
28342
American (AMR)
AF:
AC:
14740
AN:
44126
Ashkenazi Jewish (ASJ)
AF:
AC:
7024
AN:
24342
East Asian (EAS)
AF:
AC:
27212
AN:
38474
South Asian (SAS)
AF:
AC:
39147
AN:
80422
European-Finnish (FIN)
AF:
AC:
18775
AN:
53202
Middle Eastern (MID)
AF:
AC:
1005
AN:
5252
European-Non Finnish (NFE)
AF:
AC:
278760
AN:
868486
Other (OTH)
AF:
AC:
16500
AN:
51514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
13549
27098
40646
54195
67744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8266
16532
24798
33064
41330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.265 AC: 40297AN: 152184Hom.: 6737 Cov.: 32 AF XY: 0.273 AC XY: 20302AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
40297
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
20302
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
3398
AN:
41544
American (AMR)
AF:
AC:
3919
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1004
AN:
3470
East Asian (EAS)
AF:
AC:
3381
AN:
5158
South Asian (SAS)
AF:
AC:
2368
AN:
4818
European-Finnish (FIN)
AF:
AC:
3953
AN:
10592
Middle Eastern (MID)
AF:
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21384
AN:
67996
Other (OTH)
AF:
AC:
496
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1449
2899
4348
5798
7247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1775
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.